- $313.81m
- $3.60bn
- $6.00m
- 18
- 13
- 92
- 36
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Net Property, Plant And Equipment | 21 | 20 | 18 | 17 | 15 |
Long Term Investments | |||||
Insurance Receivables | |||||
Other Long Term Assets | |||||
Deferred Policy Acquisition Costs | |||||
Total Other Assets | |||||
Total Assets | 7,284 | 5,751 | 4,696 | 3,375 | 2,606 |
Accrued Expenses | |||||
Policy Liabilities | |||||
Notes Payable / Short Term Debt | |||||
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 6,445 | 5,602 | 4,996 | 4,251 | 4,253 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 839 | 149 | -300 | -876 | -1,647 |
Total Liabilities & Shareholders' Equity | 7,284 | 5,751 | 4,696 | 3,375 | 2,606 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |